Drug safety, preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
Label
Drug safety, preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
Note
Title from title screen (viewed on Dec. 12, 2007)"For release ... November 1, 2007."Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548
Acquisition source address
GAO (202)512-6000 (voice); (202)512-6061 (Fax); (202)512-2537 (TDD)
Color
mixed
Form Of Item
online
resource.govDocClassificationNumber
GA 1.5/2:GAO-08-224 T
resource.gpoItemNumber
0546-D-01 (online)
Physical Description
24 pages, digital, PDF file.
Specific Material Designation
remote
System control number
(Sirsi) o184738729
System details
Mode of access: Internet. Address as of 12/12/07: http://www.gao.gov/new.items/d08224t.pdf; current access available via PURL
Access location
Carrier category
Media category
Incoming Resources
- Item of1
Outgoing Resources
- Instantiates1
- Access location1
- Carrier category1
- Media category1
- Publication1